. 2018 Nov 19;19:328. doi: 10.1186/s12882-018-1128-6

Table 3.

Association between MEST-C score and baseline eGFR in STOP-IgAN patients

	Mean eGFR^a^,^b	p-value
Mesangial hypercellularity		0.674
M0	62 ± 26
M1	65 ± 34
Endocapillary hypercellularity		0.308
E0	64 ± 27
E1	53 ± 34
Segmental glomerulosclerosis		0.422
S0	74 ± 34
S1	61 ± 27
Tubular atrophy/Interstitial fibrosis		< 0.0001
T0	75 ± 28
T1/2	45 ± 16
Crescents		0.815
C0	62 ± 29
C1/2	64 ± 25

^aend of the 6-month run-in phase

^b ml/min/1.73m²